Orem Therapeutics Withdraws IPO... Plans to Reattempt Next Year
Bio company Orum Therapeutics announced on the 29th that it will withdraw its planned listing on the KOSDAQ market next month and will reschedule its initial public offering (IPO) for next year.
Orum Therapeutics had been preparing for the listing, including submitting a securities registration statement, until recently.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Lee Seung-joo, CEO of Orum Therapeutics, stated, "Considering the current market conditions, we judged that postponing the planned listing schedule is in the best interest of all stakeholders," adding, "We will continue to do our best to fulfill our mission of developing innovative new drugs for patients in need of treatment."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
